Perpetual Ltd lowered its stake in The Allstate Co. (NYSE:ALL - Free Report) by 97.3% in the 3rd quarter, according to its most recent filing with the SEC. The fund owned 3,575 shares of the insurance provider's stock after selling 128,619 shares during the period. Perpetual Ltd's holdings in Allstate were worth $678,000 as of its most recent SEC filing.
Other institutional investors have also modified their holdings of the company. Artemis Investment Management LLP bought a new stake in Allstate during the first quarter valued at $95,764,000. AQR Capital Management LLC raised its stake in Allstate by 181.6% during the second quarter. AQR Capital Management LLC now owns 719,997 shares of the insurance provider's stock worth $114,955,000 after acquiring an additional 464,337 shares during the period. Acadian Asset Management LLC raised its stake in Allstate by 3,839.0% during the second quarter. Acadian Asset Management LLC now owns 416,117 shares of the insurance provider's stock worth $66,417,000 after acquiring an additional 405,553 shares during the period. BNP PARIBAS ASSET MANAGEMENT Holding S.A. boosted its stake in Allstate by 757.1% in the second quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. now owns 340,274 shares of the insurance provider's stock valued at $54,328,000 after acquiring an additional 300,572 shares during the period. Finally, Atalanta Sosnoff Capital LLC bought a new position in shares of Allstate during the first quarter valued at approximately $43,909,000. Institutional investors and hedge funds own 76.47% of the company's stock.
Allstate Trading Up 1.3 %
ALL stock traded up $2.49 during mid-day trading on Friday, reaching $188.28. 1,240,617 shares of the stock traded hands, compared to its average volume of 1,546,842. The Allstate Co. has a 52-week low of $113.04 and a 52-week high of $193.97. The stock's fifty day moving average is $184.27 and its 200-day moving average is $173.03. The company has a market cap of $49.69 billion, a P/E ratio of 41.56, a P/E/G ratio of 1.74 and a beta of 0.48. The company has a current ratio of 0.36, a quick ratio of 0.36 and a debt-to-equity ratio of 0.49.
Allstate (NYSE:ALL - Get Free Report) last issued its quarterly earnings results on Wednesday, July 31st. The insurance provider reported $1.61 EPS for the quarter, beating the consensus estimate of $0.33 by $1.28. Allstate had a net margin of 5.03% and a return on equity of 24.05%. The business had revenue of $15.71 billion during the quarter, compared to the consensus estimate of $14.04 billion. During the same quarter in the prior year, the firm earned ($4.42) EPS. The firm's quarterly revenue was up 12.4% on a year-over-year basis. As a group, sell-side analysts expect that The Allstate Co. will post 15.19 earnings per share for the current year.
Allstate Dividend Announcement
The firm also recently declared a quarterly dividend, which was paid on Tuesday, October 1st. Stockholders of record on Friday, August 30th were issued a dividend of $0.92 per share. The ex-dividend date was Friday, August 30th. This represents a $3.68 dividend on an annualized basis and a dividend yield of 1.95%. Allstate's dividend payout ratio is 81.24%.
Wall Street Analysts Forecast Growth
Several analysts recently issued reports on the company. Roth Mkm reissued a "buy" rating and issued a $200.00 price target on shares of Allstate in a report on Wednesday, August 14th. Bank of America lowered their price target on shares of Allstate from $226.00 to $216.00 and set a "buy" rating for the company in a research report on Thursday. JPMorgan Chase & Co. boosted their target price on shares of Allstate from $205.00 to $207.00 and gave the company an "overweight" rating in a research note on Thursday. Evercore ISI raised their price target on shares of Allstate from $191.00 to $195.00 and gave the company an "in-line" rating in a research note on Wednesday. Finally, TD Cowen increased their price objective on Allstate from $193.00 to $224.00 and gave the stock a "buy" rating in a report on Tuesday, September 3rd. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating, fourteen have issued a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat.com, Allstate currently has an average rating of "Moderate Buy" and a consensus price target of $199.24.
Read Our Latest Stock Analysis on Allstate
Insider Activity at Allstate
In other news, insider John E. Dugenske sold 36,367 shares of the company's stock in a transaction dated Friday, September 20th. The stock was sold at an average price of $191.38, for a total value of $6,959,916.46. Following the transaction, the insider now owns 27,364 shares in the company, valued at $5,236,922.32. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In other Allstate news, insider John E. Dugenske sold 36,367 shares of Allstate stock in a transaction on Friday, September 20th. The shares were sold at an average price of $191.38, for a total transaction of $6,959,916.46. Following the completion of the sale, the insider now owns 27,364 shares of the company's stock, valued at $5,236,922.32. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, CEO Thomas J. Wilson sold 90,000 shares of the company's stock in a transaction dated Wednesday, August 21st. The stock was sold at an average price of $179.34, for a total value of $16,140,600.00. Following the completion of the transaction, the chief executive officer now directly owns 88,552 shares in the company, valued at approximately $15,880,915.68. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 238,305 shares of company stock valued at $43,082,657. Company insiders own 1.80% of the company's stock.
About Allstate
(
Free Report)
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
Recommended Stories
Before you consider Allstate, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Allstate wasn't on the list.
While Allstate currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report